Groupe d'Etude en Oncologie du Quebec

Titre	Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Protocole ID	FORUM
ClinicalTrials.gov ID	NCT01949129
Type(s) de cancer	Pédiatrique divers
Phase
Institution	CENTRE UNIVERSITAIRE DE SANTE MCGILL HOPITAL DE MONTREAL POUR ENFANTS 1001 boul. Décarie , Montréal, QC, H4A 3J1
Ville	Montréal
Investigateur(trice) principal(e)	Dr David Mitchell
Coordonnateur(trice)	Samira Mezziani 514-412-4400 poste 22930
Statut	Actif en recrutement
Critètes d'éligibilité	Patients with ALL (except for patients with B-ALL) who fulfil the following criteria: age at time of screening less than 18 years indication for allogeneic HSCT complete remission (CR) before HSCT written consent of the parents (legal guardian) and, if necessary, the minor patient via "Informed Consent Form" no pregnancy no secondary malignancy no previous HSCT HSCT is performed in a study participating centre
Critètes d'exclusion	Patients who do not fulfil the inclusion criteria Non Hodgkin-Lymphoma ALL with extramedullary involvement with indication for TBI CNS involvement at the timepoint of screening Trisomy 21 The whole protocol or essential parts are declined either by patient himself/herself or the respective legal guardian No consent is given for saving and propagation of anonymous medical data for study reasons Severe concomitant disease that does not allow treatment according to the protocol at the investigator's discretion (e.g. malformation syndromes, cardiac malformations, metabolic disorders) Karnofsky / Lansky score < 50% Subjects unwilling or unable to comply with the study procedures

Groupe d'étude en oncologie du Québec